GHRSGH Research PLC

Nasdaq ghres.com


$ 11.76 $ 0.99 (9.03 %)    

Wednesday, 01-May-2024 15:59:22 EDT
QQQ $ 424.95 $ -0.29 (-0.07 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 211.84 $ -0.62 (-0.29 %)
$ 11.95
$ 11.14
$ 0.00 x 0
$ 0.00 x 0
$ 11.03 - $ 11.76
$ 5.05 - $ 14.64
117,065
na
621.74M
$ 1.02
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-gh-research-maintains-40-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates GH Research (NASDAQ:GHRS) with a Buy and maintains $40 price tar...

 jmp-securities-maintains-market-outperform-on-gh-research-lowers-price-target-to-39

JMP Securities analyst Jason Butler maintains GH Research (NASDAQ:GHRS) with a Market Outperform and lowers the price target...

 gh-research-q4-earnings-insights
GH Research: Q4 Earnings Insights
02/29/2024 13:00:26

 psyched-suggestibility-and-psychedelics-effects-eus-7m-research-fund-australias-treatment-delivery-bz-podcast-and-more

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedel...

 psychedelics-headlines-anti-inflammatory-effects-global-drug-survey-synthetic-surprise-uks-harm-reduction-hub-and-more

Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and onli...

 hc-wainwright--co-reiterates-buy-on-gh-research-maintains-40-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates GH Research (NASDAQ:GHRS) with a Buy and maintains $40 price tar...

 psyched-100m-for-mdma-therapy-va-funds-2024-watchlist-reform-updates-and-more

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

 psyched-psychedelics-for-brain-injury-kentucky-initiative-stalled-dea-quotas-insurance-codes-50m-for-atai-and-more

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury

 atai-invests-50m-in-beckley-psytech-for-short-duration-psychedelics-development

Biopharma and resources-pooling company Atai Life Sciences (NASDAQ: ATAI) has invested a total of $50 million in Beckley Psytec...

 psyched-biden-approves-psychedelics-trials-rfk-australias-first-legal-dedicated-clinic--more

President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 Nat...

 psyched-bidens-big-decision-on-psychedelics-therapy-lsd-anxiety-results-matthew-perry-autopsy-and-more

Biden To Decide On Psychedelic Therapy Bill

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION